Brief: Icecure's Prosense Deepens Regulatory Approval In India
29/11/2023 15:56
Nov 29 (Reuters) - Icecure Medical Ltd ICCM.O :
* ICECURE'S PROSENSE® DEEPENS REGULATORY APPROVAL IN INDIA
* ICECURE MEDICAL LTD - LATEST APPROVAL, GRANTED IN NOVEMBER
2023,
CONFIRMS THAT PROSENSE® MEETS ALL UPDATED REGULATORY
REQUIREMENTS IN INDIA
Source text for Eikon: ID:nPn3KjWMBa
Further company coverage: ICCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Icecure Medical
See all newsIcecure Medical Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's IceCure Medical H1 revenue rises on higher system, probe sales
Brief: Icecure Sio Petitions Nccn To Include Cryoablation In Breast Cancer Treatment Guidelines, Citing Icecure's FDA Clearance Of Prosense®
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM